Valuation Takeda Pharmaceutical Company Limited NYSE

Stocks

TAK

US8740602052

Pharmaceuticals

Market Closed - NYSE 16:00:02 2026-09-01 EDT			5-day change	1st Jan Change
18.23 ^USD	+1.39%		-0.05%	+16.93%

08-31	Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House	MT
08-31	Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House	MT

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	5,423,454	6,762,204	6,564,378	6,749,675	8,948,061	9,333,055	-	-
Change	-	24.68%	-2.93%	2.82%	32.57%	4.3%	-	-
Enterprise Value (EV) ¹	8,919,170	10,611,015	10,950,330	10,725,175	5,130,461	13,239,572	13,036,262	12,729,222
Change	-	18.97%	3.2%	-2.06%	-52.16%	158.06%	-1.54%	-2.36%
P/E	23.8x	21.3x	45.4x	64.6x	46.4x	46.6x	29.9x	24.5x
PBR	0.95x	1.06x	0.9x	1x	1.2x	1.25x	1.25x	1.25x
PEG	-	0.5x	-0.8x	-2.5x	0.6x	16.83x	0.5x	1.1x
Capitalization / Revenue	1.52x	1.68x	1.54x	1.47x	1.99x	1.99x	1.96x	1.91x
EV / Revenue	2.5x	2.63x	2.57x	2.34x	1.14x	2.82x	2.73x	2.6x
EV / EBITDA	8.54x	9.19x	11.6x	9.71x	4.54x	9.95x	9.18x	8.58x
EV / EBIT	19.4x	21.6x	51.1x	31.3x	12.6x	29.5x	21.9x	18.5x
EV / FCF	8.92x	28.7x	43.4x	15.5x	8.14x	18.5x	18.6x	17.4x
FCF Yield	11.2%	3.49%	2.31%	6.43%	12.3%	5.4%	5.37%	5.74%
Dividend per Share ²	180	180	188	196	200	204.3	208.4	214.9
Rate of return	5.15%	4.14%	4.49%	4.44%	3.53%	3.5%	3.56%	3.68%
EPS ²	147.1	204.3	92.09	68.36	122	125.4	195.3	238.8
Distribution rate	122%	88.1%	204%	287%	164%	163%	107%	90%
Net sales ¹	3,569,006	4,027,478	4,263,762	4,581,600	4,505,700	4,694,598	4,772,892	4,892,621
EBITDA ¹	1,043,995	1,154,905	942,077	1,103,982	1,129,888	1,330,479	1,420,133	1,484,285
EBIT ¹	460,844	490,505	214,100	342,600	408,800	448,525	595,763	686,473
Net income ¹	230,059	317,017	144,067	107,900	191,800	195,073	318,478	377,294
Net Debt ¹	3,495,716	3,848,811	4,385,952	3,975,500	-3,817,600	3,906,517	3,703,207	3,396,167
Reference price ²	3,498.00	4,350.00	4,184.00	4,413.00	5,664.00	5,845.00	5,845.00	5,845.00
Nbr of stocks (in thousands)	1,550,444	1,554,530	1,568,924	1,529,498	1,579,813	1,596,759	-	-
Announcement Date	5/11/22	5/11/23	5/9/24	5/8/25	5/13/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.93x	11.96x	24.23x	0.6%	1,031B
JOHNSON & JOHNSON	29.57x	-	-	2.02%	641B
ABBVIE INC.	32.73x	7.6x	15.79x	2.67%	453B
ROCHE HOLDING AG	19.66x	4.67x	11.58x	2.83%	349B
NOVARTIS AG	21.66x	5.59x	13.87x	2.87%	290B
ASTRAZENECA PLC	20.88x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.19x	7.03x	12.5x	2.35%	232B
NOVO NORDISK A/S	13.11x	4.72x	9.86x	3.87%	201B
GILEAD SCIENCES, INC.	-44.72x	6.46x	25.22x	2.25%	181B
Average	17.00x	6.54x	15.66x	2.39%	403.31B
Weighted average by Cap.	23.95x	7.98x	17.64x	1.98%